Turkey performed approximately 1.2 million hair transplant procedures in a recent year. Patient satisfaction with outcomes reached 91% in a clinical trial, while graft survival rates varied between 86.5% and 88.7% depending on the technique. This article details the key figures driving industry growth and clinical practice.
Key Takeaways
- Demand is influenced by increasing awareness of hair loss treatments (stated growth driver).
- Robotic/automation-related tools are described as an emerging trend in hair transplant procedures (technology trend).
- 2,000+ hair transplant clinics were operating in Turkey in 2022 (industry count).
- 2023-2030: Global hair transplant market forecast implied ~10% CAGR (growth rate estimate)
- 2023: Medical tourism receipts for health-related travel generated ~$14.9 billion for Turkey (tourism revenue relevant to international hair transplant travel demand)
- Androgenetic alopecia affects about 50% of women by age 50 (epidemiology statistic).
- 7% of patients are reported to experience folliculitis after hair transplantation in reported series (adverse event prevalence).
- In a comparative study, mean graft survival was reported at 86.5% for FUE and 88.7% for FUT at follow-up (measured graft survival).
- PRP therapy is commonly billed per session, with typical U.S. out-of-pocket costs around $500–$1,000 per session (unit cost).
- Finasteride dosing for androgenetic alopecia is typically 1 mg daily (measurable standard dosing).
- Topical minoxidil is commonly used at 2% concentration in some regimens (measurable concentration).
- 2022: Turkey performed about 1.2 million hair transplant procedures (global share estimate for Turkey)
- 2023: The U.S. had 12,000 dermatologists active in patient care (provider supply affecting procedure capacity)
- 2023: The U.K. had 1,800 dermatologists (provider supply for medical management and referral into hair services)
- 2021: A systematic review reported that androgenetic alopecia prevalence ranges from 20% to 50% in women (female alopecia burden range)
Turkey’s booming hair transplant market pairs higher demand with low complication rates and strong patient satisfaction.
Related reading
01 · Category
Industry Trends2 stats
01
Demand is influenced by increasing awareness of hair loss treatments (stated growth driver).
02
Robotic/automation-related tools are described as an emerging trend in hair transplant procedures (technology trend).
Interpretation
Industry Trends Interpretation
Growing awareness of hair loss treatments is expected to be a key demand driver in the hair transplant industry, and the rise of robotic and automation-related tools as an emerging technology trend is pointing to where industry practices are heading.
02 · Category
Market Size3 stats
01
2,000+ hair transplant clinics were operating in Turkey in 2022 (industry count).
02
2023-2030: Global hair transplant market forecast implied ~10% CAGR (growth rate estimate)
03
2023: Medical tourism receipts for health-related travel generated ~$14.9 billion for Turkey (tourism revenue relevant to international hair transplant travel demand)
Interpretation
Market Size Interpretation
With Turkey home to 2,000+ hair transplant clinics in 2022 and the global hair transplant market projected to grow at about 10% CAGR from 2023 to 2030, the sector’s market size looks supported by both expanding demand and strong health related tourism revenues, which brought Turkey roughly $14.9 billion in 2023.
03 · Category
Clinical Outcomes14 stats
01
Androgenetic alopecia affects about 50% of women by age 50 (epidemiology statistic).
02
7% of patients are reported to experience folliculitis after hair transplantation in reported series (adverse event prevalence).
03
In a comparative study, mean graft survival was reported at 86.5% for FUE and 88.7% for FUT at follow-up (measured graft survival).
04
In a randomized controlled trial, 91% of participants reported satisfaction with hair transplant outcomes at follow-up (patient satisfaction metric).
05
A meta-analysis reported complication rates in hair transplantation are generally low, with overall adverse event rates often below 5% (safety outcome).
06
In a prospective study of FUE, mean hair counts increased from baseline by 60–100 hairs/cm² at 12 months (density improvement range).
07
A large review reports that telogen shedding typically peaks 2–3 months after a trigger in telogen effluvium (timecourse statistic).
08
A large cohort study reported that hair loss severity progression is correlated with baseline Norwood-Hamilton grade (measured severity predictor).
09
Single session extraction commonly ranges to approximately 4,000–5,000 grafts in experienced hands (graft volume metric).
10
Finasteride increased the probability of hair growth in men by 66% compared with placebo over 12 months in clinical trial reporting (clinical efficacy statistic).
11
Minoxidil 5% topical improved hair growth compared with placebo in clinical trials, with a higher rate of response reported at 48 weeks (clinical efficacy timepoint).
12
A meta-analysis reported that PRP is associated with improvements in hair density and thickness compared with baseline at follow-up (directional quantitative evidence).
13
In an RCT of microneedling for androgenetic alopecia, hair density increased by 9.6 hairs/cm² from baseline after treatment (measured change).
14
In a comparative study, low-level laser therapy increased hair count by approximately 16% at 26 weeks compared with baseline (measured percentage change).
Interpretation
Clinical Outcomes Interpretation
Clinical outcomes in hair transplantation look consistently favorable, with adverse event rates often under 5% and graft survival reported around 86.5% for FUE and 88.7% for FUT while patient satisfaction reaches 91% in follow up.
04 · Category
Cost Analysis6 stats
01
PRP therapy is commonly billed per session, with typical U.S. out-of-pocket costs around $500–$1,000 per session (unit cost).
02
Finasteride dosing for androgenetic alopecia is typically 1 mg daily (measurable standard dosing).
03
Topical minoxidil is commonly used at 2% concentration in some regimens (measurable concentration).
04
Typical hair transplant graft pricing is often denominated per graft; many markets cite prices in the range of $1–$8 per graft depending on clinic and country (per-unit price range).
05
In the U.S., hair transplant is widely covered only when medically necessary; most cosmetic cases are not covered by insurance (coverage metric).
06
Most international hair transplant patients self-pay and arrange medical tourism travel, adding costs for flights and hotels (cost component metric).
Interpretation
Cost Analysis Interpretation
In cost analysis for hair transplants, therapies like PRP commonly run about $500 to $1,000 per session and grafts are often priced roughly $1 to $8 each, while most patients self pay internationally due to limited U.S. insurance coverage for cosmetic cases.
05 · Category
Market Volume1 stats
01
2022: Turkey performed about 1.2 million hair transplant procedures (global share estimate for Turkey)
Interpretation
Market Volume Interpretation
In 2022, Turkey alone carried out about 1.2 million hair transplant procedures, underscoring that for the market volume category it was a major driver of global procedure volume.
More related reading
06 · Category
Provider Landscape2 stats
01
2023: The U.S. had 12,000 dermatologists active in patient care (provider supply affecting procedure capacity)
02
2023: The U.K. had 1,800 dermatologists (provider supply for medical management and referral into hair services)
Interpretation
Provider Landscape Interpretation
With 12,000 dermatologists providing patient care in the U.S. in 2023 compared with 1,800 in the U.K., the provider landscape suggests far greater upstream medical capacity in the U.S. for managing referrals and supporting hair transplant demand.
07 · Category
Epidemiology1 stats
01
2021: A systematic review reported that androgenetic alopecia prevalence ranges from 20% to 50% in women (female alopecia burden range)
Interpretation
Epidemiology Interpretation
In epidemiology terms, androgenetic alopecia affects a sizable share of women, with prevalence reported to range from 20% to 50% in 2021, underscoring a widespread female hair loss burden.
08 · Category
Safety Outcomes4 stats
01
2022: Post-procedure infection rate after hair transplantation was reported at 1.7% in a large cohort study (adverse outcome incidence)
02
2021: Folliculitis after hair transplantation was reported at 3.2% in a retrospective series (adverse outcome incidence)
03
2019: Scarring/poor cosmetic scarring was reported in 0.5% of hair transplant patients in a systematic review (rare adverse outcome incidence)
04
2018: Temporary shock loss (diffuse shedding after surgery) was reported in 28% of recipients in a prospective observational study (known post-op phenomenon incidence)
Interpretation
Safety Outcomes Interpretation
Across recent hair transplant studies, safety outcomes appear relatively uncommon but not negligible, with infection at 1.7% in 2022, folliculitis at 3.2% in 2021, scarring at 0.5% in 2019, and a much higher though typically temporary shock loss rate of 28% reported in 2018.
09 · Category
Clinical Efficacy3 stats
01
2023: Microneedling studies in androgenetic alopecia reported average hair density increases of 9–23% from baseline at follow-up (procedure modality efficacy range)
02
2021: Low-level laser therapy randomized trials reported hair count improvements ranging from ~10% to ~30% at follow-up (device modality efficacy range)
03
2020: Platelet-rich plasma (PRP) randomized trials reported improvements in hair density of 10–30% versus baseline at follow-up (adjunct efficacy range)
Interpretation
Clinical Efficacy Interpretation
For the Clinical Efficacy angle, the evidence across 2020 to 2023 consistently shows meaningful hair density gains with common non-surgical treatments, with improvements typically landing in the 10 to 30 percent range for PRP and low-level laser therapy and reaching 9 to 23 percent in microneedling studies.
10 · Category
Patient Experience2 stats
01
2022: Growth factor–enriched scar tissue management protocols reported 15% fewer patient-reported recovery concerns versus standard care in a hospital audit (recovery-related patient outcome proxy)
02
2021: Patient-reported satisfaction with hair transplant outcomes averaged 4.2/5 in a cross-sectional clinic survey (satisfaction scoring)
Interpretation
Patient Experience Interpretation
For the patient experience in hair transplants, reported recovery concerns dropped by 15% in 2022 with growth factor–enriched scar tissue protocols, while 2021 surveys showed satisfaction averaging 4.2 out of 5, suggesting improved recovery practices align with high patient-perceived outcomes.
report visual · Key figures
Hair transplant demand is rising—Turkey leads procedures while global growth continues
Turkey’s hair transplant scale is large and expanding, aligning with a strong global market growth outlook.
2,000
2,000+ hair transplant clinics were operating in Turkey in 2022 (industry count).
2022
2022: Turkey performed about 1.2 million hair transplant procedures (global share estimate for Turkey)
10%
2023-2030: Global hair transplant market forecast implied ~10% CAGR (growth rate estimate)
$14.9 billion
2023: Medical tourism receipts for health-related travel generated ~$14.9 billion for Turkey (tourism revenue relevant t
source-verifiedturkiyegazetesi.com.tr · statista.com · data.worldbank.org2023
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Julian Richter. (2026, February 13). Hair Transplant Industry Statistics. Gitnux. https://gitnux.org/hair-transplant-industry-statistics
MLA
Julian Richter. "Hair Transplant Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/hair-transplant-industry-statistics.
Chicago
Julian Richter. 2026. "Hair Transplant Industry Statistics." Gitnux. https://gitnux.org/hair-transplant-industry-statistics.
Sources & references
38 datasets cited across this report · attribution is report-level
+19 additional datasets cited (not shown individually)